Physician profile
Keith Hickey
NPI 1538100078
$7,199.94
in general payments reported to CMS, 2019-2025
38 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,844 · 2020: $1,439 · 2021: $1,682 · 2022: $1,323 · 2023: $104 · 2024: $808.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $880 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $879.86 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $938.82 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $918.22 | 2019-2022 | |
| Pfizer INC. | $822.32 | 2019-2022 | |
| Esperion Therapeutics, INC. | $386.91 | 2021-2024 | Nexletol, Nexlizet |
| Sanofi-Aventis U.S. LLC | $337.91 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $316.91 | 2019-2022 | |
| Amarin Pharma, INC. | $297.32 | 2019-2022 | |
| Novo Nordisk INC | $278.93 | 2022-2024 | Ozempic, Wegovy |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $275.94 | 2019-2023 | Lifevest |
| Merck Sharp & Dohme LLC | $247.22 | 2021-2024 | Verquvo |
| Amgen INC. | $240.60 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $217.61 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $207.79 | 2019-2023 | Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $201.19 | 2019-2024 | Jardiance |
| Regeneron Healthcare Solutions, INC. | $174.39 | 2019-2021 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $134.00 | 2019-2020 | |
| United Therapeutics Corporation | $129.99 | 2019-2022 | |
| Arbor Pharmaceuticals, INC. | $125.81 | 2019-2021 | |
| Abiomed | $125.00 | 2024 | Impella |
| Axsome Therapeutics, INC. | $121.81 | 2024 | Sunosi |
| Bayer Healthcare Pharmaceuticals INC. | $104.26 | 2021-2022 | |
| Abbott Laboratories | $85.14 | 2019-2022 | |
| Lilly USA, LLC | $76.78 | 2021-2023 | Mounjaro |
| Tactile Systems Technology INC | $69.19 | 2019-2021 | |
| Glaxosmithkline, LLC. | $60.15 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $59.10 | 2021-2022 | |
| Medtronic Vascular, INC. | $35.60 | 2019-2020 | |
| Gilead Sciences, INC. | $32.90 | 2019 | |
| Nuwellis, INC. | $27.98 | 2020 | |
| Medtronic, INC. | $26.85 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $26.58 | 2020 | |
| Boston Scientific Corporation | $21.25 | 2019 | |
| Silk Road Medical, INC. | $16.56 | 2019 | |
| Elutia, INC. | $16.53 | 2020 | |
| Impulse Dynamics (USA) INC. | $14.61 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $13.99 | 2022 | |
| Convatec INC. | $12.04 | 2022 | |
| Bardy Diagnostics, INC. | $1.74 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Hickey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.